Our Pipeline

L-Nutra is developing a pipeline of FMD-based meal programs and will pursue FDA approval for claims related to preventing, delaying or treating chronic diseases, including Cardiovascular and Autoimmune, Metabolic Syndrome, Diabetes, Cardiovascular, Cancer, Alzheimer’s, and Multiple Sclerosis.